High-Sensitivity Cardiac Troponin and Primary Prevention: An Important New Role

Affiliations

¹ Department of Cardiology, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: jaffe.allan@mayo.edu.
² Department of Cardiology, Mayo Clinic, Rochester, Minnesota.

Free article

Editorial

Allan S Jaffe et al. J Am Coll Cardiol. 2016.

Free article

. 2016 Dec 27;68(25):2729-2732.

doi: 10.1016/j.jacc.2016.11.006.

¹ Department of Cardiology, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: jaffe.allan@mayo.edu.
² Department of Cardiology, Mayo Clinic, Rochester, Minnesota.

No abstract available

Keywords: HMG-CoA reductase inhibitors; cardiac troponin; cardiovascular disease; myocyte toxicity; primary prevention.

Comment on

High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease.
Ford I, Shah AS, Zhang R, McAllister DA, Strachan FE, Caslake M, Newby DE, Packard CJ, Mills NL. Ford I, et al. J Am Coll Cardiol. 2016 Dec 27;68(25):2719-2728. doi: 10.1016/j.jacc.2016.10.020. J Am Coll Cardiol. 2016. PMID: 28007133 Free PMC article. Clinical Trial.